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Abstract.  Gelsolins are actin-binding proteins that 
cap, nucleate, and sever actin filaments. Microinjection 
of cytoplasmic or plasma gelsolin into living fibro- 
blasts and macrophages did not affect the shape, actin 
distribution, deformability, or ruffling activity of the 
cells. Gelsolin requires calcium for activity, but the 
NH2-terminal half is active without calcium. Microin- 
jection of this proteolytic fragment had marked effects: 
the cells rounded up,  stopped ruffling, became soft, 
and stress fibers disappeared.  These changes are simi- 
lar to those seen with cytochalasin, which also caps 
barbed ends of actin filaments. Attempts to raise the 
cytoplasmic calcium concentration and thereby activate 
the injected gelsolin were unsuccessful, but the in- 
creases in calcium concentration were minimal or 
transient and may not have been sufficient. Our in- 
terpretation of these results is that at the low calcium 
concentrations normally found in cells, gelsolin does 
not express the activities observed in vitro at higher 
calcium concentrations. We presume that gelsolin may 
be active at certain times or places if the calcium con- 
centration is elevated to a  sufficient level, but we can- 
not exclude the existence of another molecule that in- 
hibits gelsolin. 
Microinjection of a  1:1  gelsolin/actin complex had 
no effect on the cells. This complex is stable in the 
absence of calcium and has capping activity but no 
severing and less nucleation activity as compared with 
either gelsolin in calcium or the NH2-terminal frag- 
ment. The NH2-terminal fragment-actin complex also 
has capping and nucleating activity but no severing ac- 
tivity. On microinjection it had the same effects as the 
fragment alone. The basis for the difference between 
the two complexes is unknown. 
The native molecular weight of rabbit plasma gelso- 
lin is 82,500,  and the extinction coefficient at 280 nm 
is  1.68 cm2/mg. A  new simple procedure for purifica- 
tion of plasma gelsolin is described. 
M 
ANY proteins that bind to actin and influence its 
functional properties have been studied in recent 
years (for reviews see references 26 and 29). One 
group of these proteins bind to the barbed end of actin fila- 
ments and prevent the association and dissociation of mono- 
mers (called capping). Some proteins in this group nucleate 
the formation of filaments from monomers, and some can 
break one actin filament into two (called severing). Gelsolin 
is a well-studied example of this group. It possesses all these 
activities, requires calcium for activity, and is widely dis- 
tributed among mammalian cell types (22, 32, 33, 36-38). 
Under nonpolymerizing conditions gelsolin and actin also 
form a  1:2 complex if calcium is present.  On subsequent 
removal of calcium, one molecule of actin is removed, but 
the 1:1 gelsolin/actin complex persists (5, 20). This complex 
caps and nucleates but does not sever (6). 
Given our knowledge of the mechanism of action of gelso- 
lin in vitro, we asked whether it had similar activities and 
similar regulations in living cells and whether these activi- 
ties could affect the actin-based cytoskeleton and cell mo- 
These experiments were reported at the 1986 meeting of the American Soci- 
ety for Cell Biology (10). 
tility.  Whether gelsolin is active or not inside a cell is an 
important question because ionic and other conditions in 
cytoplasm are largely unknown and therefore cannot be du- 
plicated in vitro. Especially, activation of gelsolin requires 
calcium ions, which are maintained at low concentrations in 
cells. We asked whether, for example, the sensitivity of gel- 
solin to calcium is enhanced in cells by an unknown factor 
so that it is active at ambient cytoplasmic calcium concentra- 
tions. The approach in these experiments was to microinject 
gelsolin directly into the cytoplasm of a living cell and moni- 
tor the shape, movement, and actin distribution of the cell. 
These features are reasonable assays for gelsolin activity be- 
cause both treatment with cytochalasin and microinjection of 
other capping proteins (13) have dramatic effects on these 
features. 
Gelsolin is found in slightly different forms in cytoplasm 
and plasma. The plasma form has been called brevin 02, 15) 
and actin-depolymerizing factor (7,  8,  16). The M, of the 
plasma form is 3,000 larger than that of the cytoplasmic; this 
difference is due to an extra 25 amino acid residues at the 
NH2-terminus (34).  The two proteins are otherwise struc- 
turally similar (22, 31, 34) and are encoded by a single gene 
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ma forms are similar (11, 12) except that cytoplasmic gelsolin 
may have a higher affinity for calcium (19, 37).  The plasma 
form is easier to obtain in high purity, therefore we used plas- 
ma gelsolin in most of these experiments and then confirmed 
important  results with cytoplasmic gelsolin. 
Materials and Methods 
Proteins and Chemicals 
Ionomycin from Calbiochem-Behring Corp. (San Diego, CA) was stored in 
ethanol and diluted to its final concentration in aqueous medium before use. 
The aqueous solution was sonicated for several minutes. Fura-2, both pen- 
tapotassium and acetoxymethyl ester forms, was from Molecular Probes, 
Inc. (Eugene, OR). Other chemicals were from Sigma Chemical Co. (St. 
Louis, MO). 
Plasma geisolin was prepared from frozen rabbit plasma (Pel-Freez Bio- 
logicals, Rogers, AR) by a combination of the methods of Soua et al. (28) 
and Chapponnier et al. (8). Briefly, the procedure includes ammonium sul- 
fate fractionation, DEAE-Sepharose 6B chromatography, Sephacryl S-200 
chromatography, and Blue-Sepharose chromatography. Our assay for plas- 
ma gelsolin in column fractions was a test tube inversion assay (25)  with 
1 mg/ml rabbit skeletal muscle actin, 0.1  M  KCI, 2  mM MgC12,  1 mM 
CaC12, and 10% (vol/vol) column fraction. The purity of the final material 
varied, but only preparations >95% pure, as indicated by SDS polyacryl- 
amide gels stained with Coomassie Blue, were used for experiments. The 
activity of the pure material was documented by its ability to nucleate actin 
polymerization, a quantitative assay described by Doi and Frieden (12). The 
protein was frozen in liquid nitrogen and stored at  -70°C. 
Human plasma and platelet gelsolins were prepared using a monoclonal 
antibody as described by Hwo and Bryan (18). Alternatively, human plasma 
gelsolin and porcine plasma geisolin were purified using a simplified chro- 
matographic procedure. Briefly,  500 ml of serum (Gibco, Grand Island, 
NY) was dialyzed against 25 mM Tris/HC1,  0.5 mM CaC12, pH 7.5, ap- 
plied to a  1,000 ml DEAE-Sephacel column, and ehted with the same 
buffer.  Fractions were analyzed by SDS-gel electrophoresis and the frac- 
tions containing gelsolin were pooled. EGTA was added to 5 mM, and the 
pH was adjusted to 7.5. This material was applied to a 2.5  ×  20 cm column 
of DEAE-Sephacel equilibrated with 25  mM Tris/HC1,  pH 7.5, 0.1 mM 
EGTA. Gelsolin binds to DEAE-Sephacel in EGTA, but not in calcium and 
was eluted from the second DEAE column with a 0-0.5 M NaC1 gradient 
in 25 mM Tris/HC1,  0.1 mM EGTA, pH 7.5. We have used this method to 
purify human, bovine, porcine, chicken, and rabbit plasma gelsolins. The 
human protein shows the same activity as that purified by the immuno- 
affinity column method (18). 
To determine the extinction coefficient  of  rabbit plasma gelsolin, we mea- 
sured, with the assistance of Mr. Waiter Nulty,  protein concentration with 
the interference optical system on an analytical ultracentrifuge (model E; 
Beckman Instruments, Inc., Palo Alto, CA). For a 12 nun double sector ceil, 
4.1  fringes are equivalent to a  1 mg/ml solution (1). Our result was 1.68 
cm2/mg for A280 not corrected for light scattering, and 1.65 cm2/mg when 
corrected for light scattering (by subtracting two times A333). Weeds deter- 
mined a  value of 1.24  cm2/mg for pig plasma gelsolin by a  similar ap- 
proach  (14),  and Kilhoffer and  Gerard  (19) determined a  value of 1.63 
cm2/mg for bovine plasma gelsolin by a different method, based on amino 
acid analysis. Knowing the extinction coefficient, we determined that the 
Bradford protein assay (3) with rabbit skeletal muscle actin as standard gives 
a  value for rabbit plasma gelsolin concentration that is 95%  of the true 
value. The Bradford protein assay was used for small volumes, when absor- 
hance measurements were impractical. 
The native molecular weight of rabbit plasma gelsolin was determined, 
with the assistance of Mr. Walter Nulty, by sedimentation equilibrium in an 
analytical ultracentrifuge (model E, Beckman Instruments, Inc.). 0.2 mg/ml 
plasma gelsolin in 0.1  M  KCI,  10 mM imidazole/HCl, pH 7.0, was cen- 
trifuged in a 12 mm double sector cell at 16,000 rpm to equilibrium. A plot 
of In concentration vs. radius squared was linear, and the slope yielded a 
molecular weight of 82,400  5:1,000 (mean  5:  SD for 6  scans). The Mr 
calculated from the DNA sequence is 83,000  (21). 
The NH2-terminal half of human plasma gelsolin, called CT40,  and the 
COOH-terminal half of human plasma gel  solin, called CT45, were prepared 
as described (4). Rabbit skeletal  muscle actin was prepared and stored as 
previously described (30). BSA was labeled with lissamine rhodamine sul- 
fonyl chloride (Molecular Probes, Inc.) by the procedure of Sanger et al. 
(27).  The dye to protein ratio was 3.5:1. 
Ce//s 
3T3 cells (a mouse fibroblast line) were a girl of Dr. Luis Glaser (University 
of Miami) and were grown in DME with 10% FCS (KC Biological, Inc., 
Lenexa, KS). C3H cells (a mouse fibroblast line) were obtained from ATCC 
(American Type Culture Collection, Rockville, MD) and grown in Eagle's 
modified essential medium with 10% FCS. Chick embryo fibroblast cells 
were a girl of Dr.  Milton Schlesinger (Washington University School of 
Medicine, St. Louis, MO). J774.2 cells (a mouse macrophage line) were 
a gift of Dr. Philip Stahl (Washington University School of Medicine) and 
were  grown in  alpha  modified essential  medium  with  10%  FCS.  The 
medium was supplied by the Cancer Research Center at Washington Univer- 
sity.  Cells were grown on glass coverslips in a  5 % CO2 atmosphere and 
placed into a similar buffer with Hepes in place of bicarbonate before use. 
Microinjection 
Cells were injected at 37°C on a  Zeiss IM-35 microscope with a  Zeiss 
40×  Planapo phase contrast objective, NA 0.65, using a micromanipulator 
(Narishige Scientific Laboratory, Tokyo, Japan). The needles were pulled 
from 1 nun borosilicate Omega Dot glass capillaries (Frederick Haer & 
Co., Inc., Brunswick, ME) on a Brown-Flaming puller. The outer tip di- 
ameter was 0.2 txm by scanning electron microscopy. Proteins for injection 
were dialyzed into 150 mM KC1, 2 mM Hepes, pH 7.0, and centrifuged in 
a microfuge for 15 rain to remove dust. Before centrifugation, proteins were 
often concentrated with Centricon-30 filter apparatuses (Amicon Corp., 
Danvers,  MA).  A  fluorescent marker,  either 40,000  Mr dextran labeled 
with  FITC  (FITC-dextran)  1 or  BSA  labeled  with  lissamine rhodamine 
(LRB-BSA), was added to the solution before centrifugation. The solution 
was back-loaded into the needle, the needle was mounted on the microma- 
nipulator, and pressure was applied with a syringe. The solution was con- 
tinuously flowing through the needle during the procedure. 
In a control experiment rabbit plasma gelsolin labeled with fluorescein 
(prepared by Dr. Yukio Doi) was injected into J774.2 macrophages, and rab- 
bit plasma gelsolin labeled with lissamine rhodamine B was injected into 
C3H fibroblasts. The labeled gelsolins were active in nucleation and cap- 
ping assays with pyrene actin. The fluorescent gelsolin diffused rapidly (in 
2 min) throughout the cytoplasm. After 2 h, the fluorescence still showed 
a diffuse distribution. These results show that injected plasma gelsolin has 
rapid access to the cytoplasm and that it remains in the cytoplasm for the 
duration of these experiments. 
The injection volume was measured by a  procedure suggested by Dr. 
Daniel P. Kiehart (Harvard University, Cambridge, MA). A fluorescent im- 
age of  the injection needle containing FrlC-dextran was digitized. The cam- 
era was in its linear range, and an appropriate background image was sub- 
tracted. The path length through the needle was assumed to be equal to the 
width of the needle. Bleaching was minimized by continuous flow. Fluores- 
cent images of  injected cells were also digitized. The fluorescence at a bright 
para-nuclear area was recorded and the height of the cell at that point was 
measured by focusing with differential interference contrast optics. The fo- 
cus knob was calibrated previously. Percent volume injected was calculated 
as (cell fluorescence x  needle width  x  100)/(needle fluorescence x  cell 
height). The mean was 10%, with values ranging from 4 to 15%. Cells in- 
jected with larger volumes generally died soon after injection. 
Microscopy 
Two approaches were used. In the first, one cell was injected and time-lapse 
video records were made with a Vidicon camera and a Panasonic NV 7030 
video tape recorder. The 40x  phase contrast objective was used as above. 
The shape and ruffling activity were assessed qualitatively by viewing the 
video tape. Light that would excite the injected fluorophore was excluded 
by appropriate colored-glass long-pass filters until the end of the recording 
period when fluorescence was checked to ensure that the cell had been in- 
jected and was still alive. 
In the second approach, 20-100 cells on one coverslip were injected, 
returned to the incubator for some time, then fixed with formaldehyde and 
1.  Abbreviations used in this paper:  FITC-dextran, 40,000  Mr dextran la- 
beled with FITC; LRB-BSA, BSA labeled with lissamine rhodamine; NBD, 
7-nitrobenz-2-oxa-l,3  -diazol-4-yl. 
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lacidin; Molecular Probes, Inc.) as described (2). LRB-BSA was the fluo- 
rescent marker in these experiments because it remained in the cells after 
fixation. Photographs of phase contrast and fluorescence images were taken 
with a Zeiss Planapo 63× phase objective, NA 1.4, and Kodak Tri-X film. 
A  100-W mercury lamp was used as the light source for fluorescence. 
Cell Deformability 
The deformability of living cells was measured with a cell-poking device 
that indents cells with a glass microprobe. The instrument and its operation 
have been described (23, 24). Cells were injected on the IM-35 as described 
above and placed onto the cell-poking device. The temperature was 33°C. 
Maximum depth of indentation was <2.6 gm. Velocity of indentation was 
5.5 gm/s, and the poker tip diameter was "~2 gm. Flat,  well-spread cells 
were indenWat in a para-nuclear area of cytoplasm, and small round cells 
were indented in their center. Cell appendages, such as ruffles and filopodia, 
are too small to have an effect on this measurement, which reflects proper- 
ties of bulk cytoplasm. Stiffness was calculated as the linear slope of the 
initial portion of the force vs. displacement curve, corresponding to the ini- 
tial phase of the indentation. 
Permeabilized Cell Models 
Fibroblasts on glass coverslips in culture were washed twice quickly with 
150 mM NaCI, 5  mM Hepes, pH 7.2, and permeabilized for  120 s  with 
HKM buffer (150 mM KC1, 2 mM MgCI2, 2 mM Hepes, pH 7.0) plus 0.1% 
(wt/vol) Triton X-100. The cells were rinsed with HKM buffer twice quickly 
and then incubated with various solutions for 30 rain. They were rinsed with 
HKM buffer twice quickly, fixed with formaldehyde, and stained with NBD- 
phallacidin as above. 
Calcium Measurements with Fura-2 
Fibroblasts were either loaded with Fura-2/AM ester or micminjected with 
Fura-2/K  + salt. Cells were loaded with ester by incubating them in normal 
medium with 20 ~tM Fura-2/AM for 45 rain at 37"C or several hours at 4oC 
(to minimize uptake of dye by pinocytosis). The cells were washed briefly 
with Hepes-based medium and placed either on the Zeiss IM-35 microscope 
or in an Aminco fluommeter (SLM Instruments, Inc., Urbana, IL) at 37°C. 
On the microscope, fluorescent images were recorded with excitation band 
pass filters at 340 and 380 nm. A Zeiss 100x Ultrafluor objective was used. 
The Dage ISIT video camera was used at high sensitivity, and neutral den- 
sity filters were placed in the excitation path to minimize bleaching. Back- 
ground images, recorded from areas of  the coverslip with no cells, were sub- 
tracted from the cell images, and the ratio of the 340 to the 380 image was 
calculated. A threshold value was applied during the ratio process, to avoid 
spuriously high ratio values at the cell edge, where the fluorescence values 
are low. Values were averaged over a 10 x  10 pixel area. Standard solutions 
of EGTA-buffered calcium with Fura-2K  + were then placed on the micro- 
scope with the same settings as used for cell images. 340- and 380-um im- 
ages were recorded and backgrounds of solution without Fura were sub- 
tracted. The resulting ratios were used to calibrate the cell ratios. With the 
fluorometer, fluorescence was recorded with excitation at 340 and 380 run, 
emission  at 510 nm, excitation band width of 5 urn, and emission  band width 
of 20 nm. Background fluorescence, from cells that were not loaded with 
Figure 1.  Microinjection of plasma gelsolin into fibroblasts. The micrographs are,  left to right, phase contrast, NBD-phallacidin fluores- 
cence, and LRB-BSA fluorescence. The LRB-BSA image shows which cell was injected. The cells have a normal spread shape, with actin- 
containing stress fibers (top) and  membrane ruffles (bottom).  Bar,  10  ~tm. 
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Figure 3. Deformability of cells. The percent of cell stiffness for in- 
jected vs. uninjected cells is plotted for six different experiments. 
These data are also listed in Table I. Cells were injected with plas- 
ma  or  cytoplasmic  gelsolin,  NH2-terminal  fragment  of gelsolin 
(CT40), or treated with cytochalasin D. Each bar represents one ex- 
periment, performed on a day separate from the other experiments. 
The error marks are  1 SEM. 
Fura, was subtracted from each value and ratios were calculated. Calcium 
standard solutions, described above, were used to calibrate the ratios. 
For micminjection, fibmblasts were placed on the microscope with the 
optics described above and injected with 500 lxM Fura-2/K  ÷ in 150 mM 
KC1.  In  some experiments  1 mM CaCI2 was included  in the injection 
buffer.  Many injected cells lost their fluorescence over several minutes, 
whether calcium was in the solution or not. This phenomenon does not oc- 
cur with injections of Lucifer Yellow or FITC-dextran in our hands and we 
have no good explanation for it. We prefer microinjection of salt to loading 
with ester because less dye associates with vesicles and it avoids the poten- 
tial problem of partially hydrolyzed ester that is trapped but not responsive 
to calcium. 
Results 
Microinjection of plasma gelsolin into living cells had no 
effect on their shape,  actin distribution, deformability, or 
ruffling. Fibroblasts were injected with 30-38  lxM plasma 
gelsolin and incubated for 15 min to 2 h. The concentrations 
given for this and other microinjection experiments repre- 
sent the concentration of protein in the needle, not the in- 
jected cell. 30-80 cells were injected on each coverslip and 
each experiment was  repeated at least once.  The injected 
cells were well-spread with a normal complement of stress 
fibers and ruffles (Fig. 1). This experiment was repeated with 
gelsolin prepared from rabbit, human, and pig plasma. Mac- 
rophages were injected with 30 ~tM rabbit plasma gelsolin 
and the motility of single cells was followed with time-lapse 
video microscopy (Fig.  2 a). The shape and extensive ruf- 
fling activity of these cells was unaffected by the injection 
compared with injection of similar concentrations of BSA 
(Fig. 2 b). These observations are qualitative and subjective. 
However, cell deformability, which is a quantitative and ob- 
jective measurement of the state of the cytoskeleton, also 
showed no difference between fibroblasts injected with rabbit 
Table L Deformability of Cells 
Deformability  (mean  +  SEM) 
Treatment  Injected  Uninjected  Percent 
mdyn/,m  mdyn/pm 
Plasma gelsolin  0.25  +  0.02  0.26  +  0.04  96 
Cytoplasmic gelsolin  0.20  +  0.02  0.19  +  0.02  105 
Fragment of plasma gelsolin  0.04  +  0.01  0.26  4- 0.03  15 
0.07  4- 0,01  0.20  4- 0.02  35 
Low dose  0.21  4- 0.03  0.20  4- 0.02  105 
Cytochalasin D  0.10  4- 0.03  0.21  4- 0.07  48 
0.07  +  0.01  0.20  4- 0.02  35 
Plasma gelsolin/actin complex  0.22  4- 0.02  0.24  4- 0.03  92 
Controls 
FITC-dextran  0.24  +  0.06  0.21  4- 0.07  114 
LRB-BSA  0.22  +  0.02  0.24  -t- 0.03  92 
Ionomycin/calcium treatment 
Plasma gelsolin (30 min)  0.28  4- 0.04  0.31  4- 0.06  90 
Plasma gelsolin (110 min)  0.41  4- 0.08  0.40  4- 0.08  103 
LRB-BSA (60 min)  0.23  +  0.02  0.24  4- 0.03  95 
Injections with calcium 
Plasma gelsolin  0.20  +  0.01  0.19  4- 0.02  105 
0.20  +  0.02  0.17  4- 0.01  118 
Cytoplasmic gelsolin  0.18  4- 0.02  0.19  4- 0.02  95 
BSA  0.57  +  0.06  0.55  4- 0.07  104 
The values represent the stiffness of cells during the initial portion of the inden- 
tation,  where force vs.  displacement  is relatively  linear.  Living cells were 
microinjected  with  38  ~tM  plasma  or  cytoplasmic  gelsolin.  NH2-terminal 
fragment of plasma gelsolin, or plasma gelsolin/actin  complex. Control injec- 
tions were with 2 mg/ml F1TC-dextran or 0.3 mg/ml LRB-BSA. Cytochalasin 
D treatment  consisted of 2 laM extracellular  cytochalasin  D for 30 rain.  The 
"uninjected" values for the cytochalasin  treatments represent ceils from other 
coverslips on the  same day  that  were  not treated with cytochalasin.  For 
ionomycin/calcium  treatment,  the ionomycin concentration  was 1.3 IxM, ex- 
tracellular  calcium  concentration  was 2 mM, and extracellular  pH was 8.1. 
When calcium was included in the injection buffer, its concentration  was 500 
I.tM. 
The number of cells in each group was 15-50.  This value is included in cal- 
culation  of SEM. In these data, the conclusion  that two populations  are the 
same (i.e., not different)  is not justified for the many cases where the values 
appear to be the same, because of beta (type II) error. For example, with 30 
data points in each sample, one has a 90% chance of detecting the difference 
between means of 0.25  and 0.16 (a 35 % difference) given our typical  SD of 
0.10. 
plasma gelsolin and cells  not injected  (Fig.  3;  Table  I). 
Microinjection of similar concentrations of cytoplasmic gel- 
solin from human platelets into fibroblasts also had no effect 
on cell shape, actin distribution, or cell deformability (Figs. 
3 and 4; Table I). 
Because gelsolin requires calcium for activity, we injected 
a fragment of gelsolin that does not need calcium to be ac- 
tive.  The  NH2-terminal  half of plasma  gelsolin  (CT40), 
produced by chymotryptic  proteolysis, has the full functional 
activity of the intact molecule but is active without calcium. 
Microinjection of this  fragment at  38  IxM had dramatic 
effects on all injected cells. Fibroblasts rounded up and stopped 
ruffling. Their stress fibers were lost, and perinuclear punc- 
tate structures were  seen with the NBD-phallacidin stain 
(Fig.  5).  The cells became very soft in the deformability 
measurements (Fig. 3; Table I). These effects resemble those 
Figure 2. Microinjection of macrophages. Selected phase contrast images from a time-lapse video record are shown. The times indicated 
are minutes after injection. The injected protein was (a) plasma gelsolin, (b) BSA, or (c) NH2-terminal fragment of gelsolin (CT40).  In 
a  and b  the injected cells maintain their spread shape and ruffling activity, but in c  the cell rounds up and stops ruffling. Bar,  10  ~m. 
Cooper et al.  Gelsolin Microinjection  495 Figure 4.  Microinjection of fibroblasts with cytoplasmic gelsolin. The micrographs are, left to right, phase contrast, NBD-phaUacidin 
fluorescence, and LRB-BSA fluorescence. (Top to bottom)  (a) no calcium treatment; (b) 500 I~M CaCI2 in injection solution; (c) ionomy- 
cin/calcium treatment after injection; (d) 500 ~tM CaCI2 in injection solution and ionomycin/calcium treatment after injection. The in- 
jected cells in a  and b are normal. Cells treated with ionomycin (c and d) are slightly retracted with partial loss of stress fibers, but the 
injected cells still resemble the uninjected ones. Bar,  10 I~m. 
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contrast, NBD-phallacidin fluorescence, and LRB-BSA fluorescence. Injected cells are round, having left a thin network of cytoplasm at- 
tached to the coverslip. Fluorescence shows the loss of stress fibers and appearance of perinuclear punctate stain. Bar, 10 ~tm. 
of cytochalasin D (Figs. 3 and 6; Table I). Macrophages also 
rounded up and stopped ruffling (Fig. 2  c). 
The injection added 3-4 gm of gelsolin to the cells based 
on our measured injection volume of 10%.  The concentra- 
tion of endogenous gelsolin in cells is not known precisely, 
but Soua et al. (28) measured 1-4 ~tg gelsolin/mg protein in 
a variety of tissues. If cells contain 75 mg protein/ml, then 
the gelsolin concentration is 1-4 gM. Therefore the injection 
introduces a quantity similar to that already present. The ac- 
tin polymer concentration is ~100 ~tM, so a molar ratio of 
about 1 gelsolin fragment to 30 actin protomers is present 
when the dramatic effects are seen. 
In both types of cells the effects began immediately upon 
injection and persisted without reversal for up to 6  h  (the 
longest time point examined). Microinjection of lower con- 
centrations,  18 and 9  gM,  of NH2-terminal fragment into 
fibroblasts caused similar effects on shape and actin distribu- 
tion, but the effects were variable and less pronounced. Some 
cells showed loss of stress fibers, either partial or total, with- 
out rounding up. Microinjection of the COOH-terminal half 
of human plasma gelsolin (CT45) at 38 lxM had no effect on 
the shape or actin distribution of fibroblasts (no micrographs 
are shown). 
We attempted to activate plasma gelsolin in the injected 
cells by increasing intracellular calcium with ionophores and 
calcium injections. Treatment of gelsolin-injected cells with 
1.3  gM  ionomycin or 0.5  gM  A23187  in the presence of 
2 mM extracellular calcium had no effect (micrographs not 
shown; Table I). Raising the extracellular calcium to 12 mM 
in such an experiment caused many injected and uninjected 
cells to die as indicated by the loss of LRB-BSA (the fluores- 
cent marker), but the  surviving cells showed none of the 
changes described above with the  NH2-terminal fragment 
(Fig. 7). Raising the pH of the medium to 8.1 increases the 
effectiveness of ionomycin and ultimately caused all the cells 
to die. With shorter treatment times, cells were slightly re- 
tracted with partial loss of stress fibers, but again there was 
no difference between injected and uninjected cells (Fig. 4, 
c and d). In other experiments 0.5 mM calcium was included 
with gelsolin in the injection solution. A larger fraction of 
the injected cells died but the survivors were not different 
from uninjected cells (Fig. 4, b and d; Table I). 
The intracellular calcium concentration was measured in 
fibroblasts either injected with Fura-2  salt or loaded with 
Fura-2 ester. Fluorescence measurements were made both 
by digital microscopy on single cells and by fluorometry on 
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chalasin D. Phase contrast and NBD-phalla- 
cidin  fluorescence  micrographs  are shown. 
The shape and actin distribution of the cells 
am  similar  to  those  of  fragment-injected 
cells. Bar, 10 ~m. 
populations of cells. The resting calcium was 70 nM. Treat- 
ment of cells with 1.3 ~tM ionomycin and 2 mM extracellular 
calcium at pH 7.4 only raised the calcium to 270 nM. When 
1 mM calcium was included with the Fura-2 salt in the injec- 
tion buffer, the initial intracellular calcium measurement was 
100 gM, but by 12 min it fell to 200 nM. These results show 
that the ceils control their intracellular calcium concentra- 
tion so well that the ionophores and calcium treatments can- 
not raise the calcium high enough to activate microinjected 
plasma or cytoplasmic gelsolin.  The cells probably die be- 
fore their calcium concentration rises to a  sufficient level. 
As another positive control, we examined whether plasma 
gelsolin could remove stress fibers from permeabilized cell 
models in which the calcium was high enough to activate the 
gelsolin. Triton-permeabilized fibroblasts were treated with 
0.3  I~M plasma gelsolin  and  100  gM  CaC12 for  30  min. 
Stress fibers were totally removed (Fig.  8). 
To ask whether the capping, nucleating, or severing activ- 
ity of the  NH2-terminal fragment (CT40)  was  responsible 
for the effects on ceils upon microinjection, we injected two 
gelsolin preparations that do not sever. Gelsolin can be made 
to form a  1:1 complex with actin, which is active in the ab- 
sence of calcium. Calcium is required for the formation of 
the  complex,  but  on  subsequent  chelation  of calcium the 
complex dissociates very slowly, with a  half-time of 30 d. 
The complex has capping and partial nucleation activity but 
no severing activity (6).  We confirmed this for our prepa- 
ration of rabbit plasma gelsolin by measuring the effect of 
the  complex on the kinetics of actin polymerization from 
monomers and the final steady state level of polymerization 
with pyrene actin fluorescence. For microinjection, plasma 
gelsolin was mixed with actin in a 1:2 molar ratio in the pres- 
ence of 100  ~tM CaC12. After 10 min,  100  ItM EGTA was 
added and the complex was concentrated to 36 ~tM. Injection 
of the complex into fibroblasts had no effect on cell shape and 
actin distribution (micrographs not shown) and cell deform- 
ability (Table I). A  complex of CT40 with actin was made 
by mixing 2.5 mol of actin per tool of CT40, and it was dia- 
lyzed into injection buffer. The absence of severing activity 
was confirmed by a depolymerization assay with pyrene ac- 
tin and by a cytoskeleton assay like the one in Fig. 8. Injec- 
tion of this complex at 39 ltM into fibroblasts had dramatic 
The Journal of Cell Biology, Volume 104,  1987  498 Figure 7. Ionomycin/calcium treatment of fibroblasts injected with plasma gelsolin. After injection with 38 ~tM rabbit plasma gelsolin, 
cells were incubated for 60 min with 1.3 btM ionomycin and 12 mM CaC12 at pH 7.4. All the cells are slightly retracted with partial loss 
of stress fibers, but there is no difference between injected and uninjected cells. Bar,  10 I.tm. 
Figure 8.  Effect of plasma gelsolin and calcium on stress fibers in permeabilized fibroblasts. Fibroblasts were permeabilized with Triton 
and then treated with a solution of 0.3 I.tM plasma gelsolin and  100 laM CaCl2.  Control cells, treated with calcium but not gelsolin, are 
shown in the upper panel and gelsolin-treated cells are below. Bar,  l0 gin. 
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those of the fragment alone shown in Fig.  5.  The micro- 
graphs from this experiment are not shown. 
Discussion 
The first step toward understanding the physiologic role of 
gelsolin is to determine whether it can be active in the envi- 
ronment of cytoplasm. In these experiments we injected gel- 
solin  into  living  cells  and  observed  no effect on  various 
parameters of cell motility and the actin-based cytoskeleton. 
Gelsolin-injected cells  had  normal  shape  and  membrane 
ruffling.  The distribution  of actin  filaments,  observed by 
fluorescence microscopy, was unchanged. Cell deformabil- 
ity, a quantitative measurement that mainly reflects the state 
of actin  (24),  was  also unchanged.  We conclude that the 
majority of the injected gelsolin is not active in living cells, 
and therefore infer that the majority of the endogenous gelso- 
lin is also not active. The conclusion is limited by the cell 
types, fibroblasts and macrophages, the functional state of 
the cells,  and the parameters of cell motility examined in 
these experiments. 
Is gelsolin not active because of a lack of calcium? To an- 
swer this question we injected a proteolytic fragment of gel- 
solin that  has  all  the  activities,  capping,  nucleation,  and 
severing, of gelsolin but does not require calcium (4). Injec- 
tion of this fragment at concentrations similar to those used 
for the ineffective gelsolin injections markedly affected all of 
the observed cell parameters: shape, ruffling, actin distribu- 
tion, and deformability. This positive result serves as a con- 
trol to show that the negative result with intact gelsolin is 
valid. These results also suggest that the injection of gelsolin 
is ineffective because the calcium concentration in the cells 
is too low for gelsolin to be active. 
We attempted to confirm this conclusion by raising the cal- 
cium concentration in cells injected with gelsolin. Neither 
treatment with calcium ionophores and high  extracellular 
calcium nor injection of calcium activated the injected gelso- 
lin. The most severe treatments simply killed the cells. The 
intracellular calcium  concentration, measured by fluores- 
cence of Fura-2, increased only from 70 to 270 nM with these 
treatments. Should gelsolin have been active at these concen- 
trations of calcium? Direct binding studies show that both 
macrophage and platelet cytoplasmic gelsolins bind 2 mol of 
calcium with a dissociation constant of 1 IxM (5,  37),  and 
titration  of  fluorescence  polarization  shows  that  bovine 
plasma gelsolin binds more than 1 mol of calcium with a dis- 
sociation constant of 20 I~M (19). Therefore our treatments 
probably did not increase the calcium concentration enough 
to activate most of the injected gelsolin.  The injections of 
lower  concentrations  of fragment  show  that  most  of the 
injected gelsolin would have to be active to produce a de- 
tectable effect on the cells. The absence of an effect when 
calcium was injected with gelsolin is more difficult to under- 
stand. The calcium concentration fell rapidly, perhaps before 
gelsolin could act. 
Our interpretation of these results is that gelsolin, which 
is present in cytoplasm at a substantial concentration, is nor- 
mally inactive due to the low concentration of calcium, "~0.1 
laM. These molecules may be activated by an increase of the 
calcium concentration to the range of 1 RM. Another possi- 
bility, although less likely in our view, is that gelsolin is in- 
hibited by another protein, which is currently undescribed, 
and is activated by relief of this inhibition. Cytoplasmic gel- 
solin can be isolated uncomplexed with actin (27),  which 
supports the view that it is an unactivated state in cells. If gel- 
solin is activated and interacts with actin before isolation, it 
is obtained as a complex with actin, which is irreversible to 
the removal of calcium ions (5, 20). It is also possible, how- 
ever, that there is a constituent of cytoplasm that can dissoci- 
ate gelsolin/actin complexes (9).  Why do cells apparently 
retain substantial quantities of cytoplasmic gelsolin in an in- 
active state? One possible explanation is that cell activities 
that require active gelsolin involve only a localized portion 
of the cell and are activated by a local and transient signal 
such as an increase in calcium concentration. Possible ex- 
amples of such functions include phagocytosis, exocytosis, 
milling, and locomotion. As our attempts to increase intra- 
cellular calcium concentration suggest, a local increase would 
dissipate very rapidly. Hence, a high concentration of gelso- 
lin at the site of the transient rise in ion concentration might 
be necessary to yield a  sufficient quantity of the activated 
protein. A direct test of this idea would require a correlation 
of local increases in calcium ion concentration with local ac- 
tivation of gelsolin. 
Other capping proteins do not require calcium for activity, 
and previous microinjection experiments showed that brain 
capping protein and Physarum  42(a +  b) capping protein can 
disrupt the stress fibers of fibroblasts (13). Gelsolin may be 
involved in calcium-mediated processes, whereas these other 
proteins may be constitutively active or regulated in other 
ways. 
The results obtained with the gelsolin fragment also indi- 
cate what types of effects gelsolin might have on ceils. The 
most novel finding, based on a quantitative assay on living 
cells, is that the mechanical properties of cytoplasm can be 
changed by gelsolin. Another finding is that stress fibers can 
be disrupted.  Such a disruption is associated with mitosis 
and translocation (17). Also, ruffling can be inhibited, and 
cells can round up.  These findings are predicted from the 
mechanism of action of gelsolin on actin in vitro, and show 
that capping proteins, when active, can have powerful effects 
on several aspects of cell motility. 
Gelsolin has capping, nucleating, and severing activities. 
To test which of these activities causes the effects seen on in- 
jection of the  NH2-terminal fragment,  we injected gelso- 
lin/actin and fragment/actin complexes. Neither complex has 
severing activity, but both cap and nucleate. Surprisingly, the 
two complexes have different effects on cells.  The gelso- 
lin/actin complex has no effect and the fragment/actin com- 
plex has the full effect of the fragment alone. This result sug- 
gests three possible interpretations, which can be tested in 
future experiments. First, cells may possess a mechanism to 
dissociate the complexes, which are very stable in vitro. The 
free gelsolin would be inactive, and the free fragment would 
be active. Second, another molecule may interact with gelso- 
lin, but not the fragment, to inactivate the complex. Third, 
the capping and nucleating activities of the two complexes 
may not be quantitatively identical. 
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Note Added in Proof:  We refer the reader to two recent publications that 
describe some experiments similar to these: Fiichtbaner, A., B. M. Jock- 
usch,  E.  Leberer,  and  D.  Pette,  1986,  Proc.  Natl.  Acad.  Sci.  USA., 
83:9502-9506;  and Jockusch, B. M., A. Fiichtbauer, C. Wiegand, and B. 
H6ner, 1986, In Cell and Molecular Biology of the Cytoskeleton, J. W. Shay, 
editor,  Plenum Publishing Corp., New York, 7:1-40. 
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